Filed before 2025Filed 3 February 2012
Allozyne Inc raised $2.5M
Allozyne Inc, a biotech company based in Seattle, WA, raised $2.5M in a new debt round, according to a filing dated 3 February 2012.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 February 2012
- Round
- Debt round
- Amount sold
- $2.5M
- Offering size
- $4M
- Investors so far
- 5
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 34% of the 368 tracked raises with an amount filed in 2012, and than 44% of the 32 in biotech.
Allozyne Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 3 Feb 2012 | New filing | $2.5M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.